Experimental group:EBV TCR-T cell therapy

2 trials

Sponsors

Affiliated Hospital of Xuzhou Medical University

Conditions

Recurrent/refractory EBV nasopharyngeal lymphomaRelapsed/Refractory EBV Nasopharyngeal Carcinoma

Early Phase 1

A clinical study for the safety and preliminary effectiveness of EBV TCR-T cells in the treatment of patients with relapsed/refractory EBV-positive lymphoma

Active, not recruitingChiCTR2100050405

Affiliated Hospital of Xuzhou Medical UniversityRecurrent/refractory EBV nasopharyngeal lymphoma

Start: 2021-09-20Updated: 2022-05-02

A clinical study on the safety and preliminary effectiveness of EBV TCR-T cells in the treatment of patients with relapsed/refractory EBV-positive nasopharyngeal carcinoma

RecruitingChiCTR2100050521

Affiliated Hospital of Xuzhou Medical UniversityRelapsed/Refractory EBV Nasopharyngeal Carcinoma

Start: 2021-09-20Updated: 2022-05-02